Subscribe to RSS Feed
Janssen announces IMBRUVICA®▼ (ibrutinib) is reimbursed in three forms of blood cancer with limited treatment options
First-in-class BTK inhibitor for complex orphan diseases CLL, MCL and WM1
Moving from Statement to Implementation
EAHP's General Assembly approves 5-year plan for implementation
EAHP welcomes Montenegro and FNSIP-BM as its newest members
The European Association of Hospital Pharmacists (EAHP) is delighted to announce further expansion of its membership, with the addition of a new country...
Campaign urges women to make folic acid a daily habit
• Only 1 in 4 women take folic acid before pregnancy
Men United - for Health and Wellbeing: Martin O’Neill and Michael O’Neill unite to launch Men’s Health Week
National Football Managers, Martin O’Neill and Michael O’Neill, have joined forces to help to launch International Men’s Health Week, reminding Irish men...
Hospital pharmacists from across Europe gather in Prague for EAHP General Assembly
Hospital pharmacists from across Europe are gathering in Prague today (9th June) for the annual General Assembly of the European Association of Hospital...
New Cervical Cancer Guideline addresses global resource disparities
ALEXANDRIA, Va. - The American Society of Clinical Oncology (ASCO) today issued its first clinical practice guideline on invasive cervical cancer. This...
Progress in science, medicine and health. EMA publishes 2015 annual report
The European Medicines Agency’s (EMA) 2015 annual report published today focuses on the Agency’s core tasks which include the evaluation of medicines,...
New treatment for rare white blood cell cancer
Treatment of follicular lymphoma to be added to Gazyvaro’s approved uses
New treatment for patients with multiple myeloma
Darzalex recommended for conditional approval
ECCO'16 Press Conference: ECCO-EFCCA Patient Guidelines
Press conference at the 11th Congress of ECCO – Inflammatory Bowel Diseases (Amsterdam, March 16, 2016)
Sneaking through barrier gaps: Gut microbiota imbalance harms the liverSneaking through barrier gaps: Gut microbiota imbalance harms the liver
(March 14, 2016) The potential consequences of gut microbial dysbiosis are not restricted to bowel conditions only. Prominent among the other organs that might...
Launch of PRIME – Paving the way for promising medicines for patients
New scheme supports European Commission priorities
Queen’s chemists devise new approach for rapidly identifying ‘legal highs’
Chemists from Queen’s University Belfast have developed a new approach which now allows for rapid screening and identification of ‘legal highs’ or novel...
Cardiorentis’ Ularitide could make waves in Acute Decompensated Heart Failure market, says GlobalData Analyst
• Ularitide, a recently fast-tracked drug in development for acute decompensated heart failure, has the potential to bring valuable new therapeutic options to...
New ADHD Drug Adzenys Addresses Unmet Need for Patients who Struggle to Swallow Tablets, says GlobalData Analyst
• Neos Therapeutics’ new ADHD drug, Adzenys, is set to address problems associated with patients who struggle to swallow tablets